Flubromazepam

Flubromazepam is a benzodiazepine derivative which was first synthesized in 1960, but was never marketed and did not receive any further attention or study until late 2012 when it appeared on the designer drug market as a novel research chemical. It produces long-acting anxiolytic, sedative, muscle relaxant, and amnesic effects.

Chemistry[edit | edit source]

Flubromazepam is a structural analogue of diazepam. It differs from diazepam in that the benzene ring has been replaced by a thiophene ring and fluorine has been added to the 2' position of the 4-phenyl ring.

Pharmacology[edit | edit source]

Flubromazepam is a long-acting psychoactive substance of the benzodiazepine class which produces anxiolytic, sedative, muscle relaxant, and amnesic effects. Benzodiazepines produce a variety of effects by binding to the benzodiazepine receptor site and magnifying the efficiency and effects of the neurotransmitter gamma aminobutyric acid (GABA) by acting on its receptors.

Legality[edit | edit source]

As of October 2015, flubromazepam is a controlled substance in China. Flubromazepam is illegal in Lithuania, and Sweden made it illegal in January 2016.

References[edit | edit source]

External links[edit | edit source]

EMCDDA Drug profiles: Benzodiazepine

Flubromazepam Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.